Search

Author/Creator Warren, D.

3. OP0017 THERAPEUTIC DRUG MONITORING COMPARED TO STANDARD TREATMENT OF PATIENTS STARTING INFLIXIMAB THERAPY: RESULTS FROM A MULTICENTRE RANDOMISED TRIAL OF 400 PATIENTS. (2nd June 2020)

Authors:
Syversen, S. W.; Goll, G. L.; Jørgensen, K. K.; Sandanger, Ø.; Sexton, J.; Olsen, I.; Gehin, J.; Brun, M. K.; Warren, D.; Mørk, C.; Kvien, T. K.; Jahnsen, J.; Bolstad, N.; Haavardsholm, E. A.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79(2020)Supplement 1
Page Start:
12
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Proceedings of the 2014 Spring Meeting of the Society of British Neurological Surgeons. (2014)

Authors:
James, G.; Tisdall, M. M.; Varadkar, S.; Cross, J. H.; Harkness, W. F. J.; Galea, J. P.; Hinkley, M.; Laitt, R.; Vail, A.; Dulhanty, L.; Patel, H. C.; Kwok, H.-T.; Baxter, D.; deFelice, J.; Hellyer, P.; Kirkman, E.; Watts, S.; Midwinter, M.; Gentleman, S.; Sharp, D.
Journal:
British journal of neurosurgery
Issue:
Volume 28:Number 2(2014:Apr.)
Page Start:
142
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. THU0123 Non-Medical Switch from Originator To Biosimilar Infliximab among Patients with Inflammatory Rheumatic Disease – Impact on S-Infliximab and Antidrug-Antibodies. Results from The National Danish Rheumatologic Biobank and The Danbio Registry. (15th July 2016)

Authors:
Glintborg, B.; Kringelbach, T.; Høgdall, E.; Sørensen, I.J.; Jensen, D.V.; Loft, A.G.; Hendricks, O.; Jensen Hansen, I.M.; Bolstad, N.; Grøn, K.; Eng, G.; Enevold, C.; Nielsen, C.H.; Warren, D.; Goll, G.; Gehin, J.; Johansen, J.S.; Hetland, M.L.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 75(2016)Supplement 2
Page Start:
224
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗